Additionally, inhibiting Wee1 not only triggers cell cycle arrest and suppresses the development of cancer cells but also enhances CML cell sensitivity to IM in vitro and in vivo. The gene discussed is WEE1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.